Synopsys' $34.9B Ansys Deal Boosts Revenue and Scale but Crushes EPS, Raises Debt Risk

Synopsys, Inc. (SNPS) - NASDAQ

Quick read - what's happening inside the company
Synopsys completed the acquisition of Ansys on July 17, 2025 (total consideration ~$34.9 billion). The deal materially reshaped the balance sheet: goodwill and intangibles ballooned and debt was raised to fund the cash portion. Core product revenue grew year‑over‑year, led by Design Automation and hardware demand, while the Design IP business underperformed (China export controls and customer headwinds cited). Management has suspended the buyback program and is reallocating resources inside the IP business.

Key points & statistics (as reported; amounts are in thousands unless otherwise noted)
- Revenue (Three months ended July 31, 2025): $1,739,737 (up $214,0­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­00 vs Q3 2024; +14%).
- Gross margin (Q3 2025): $1,359,173.
- Operating income (Q3 2025): $165,269 vs $360,211 in Q3 2024 (sharp decline).
- Net income attributed to Synopsys (Q3 2025): $242,509 vs $408,055 in Q3 2024.
- Diluted EPS (Q3 2025): $1.50 vs $2.61 (Q3 2024).
- Nine months revenue (YTD July 31, 2025): $4,799,318 vs $4,491,450 (YTD +7%).
- Cash & cash equivalents (July 31, 2025): $2,526,475; short‑term investments: $67,235; total cash & short‑term investments: $2,593,710.
- Total assets (July 31, 2025): $48,230,256 (up from $13,073,561) - reflects Ansys acquisition.
- Goodwill (July 31, 2025): $26,945,723 (vs $3,448,850 Oct 31, 2024).
- Intangible assets, net (July 31, 2025): $13,079,912 (vs $195,164 Oct 31, 2024).
- Total liabilities (July 31, 2025): $20,616,070 (vs $4,050,355 Oct 31, 2024).
- Long‑term debt (July 31, 2025): $14,318,016. Senior Notes and term loans issued in 2025 total principal shown ~ $14,300,000.
- Backlog (contracted but unsatisfied obligations): approximately $10.1 billion as of July 31, 2025.
- Cash provided by operating activities (nine months ended July 31, 2025): $878,870.
- Effective tax rate (Q3 2025): (28.0)% - driven by tax benefits including valuation allowance release on California R&D credits.

Positive aspects (income statement and operations)
- Top‑line growth: revenue increased quarterly and YTD; Design Automation showed strong performance and hardware demand.
- Strong cash generation: operating cash flow for the nine months was $878,870.
- Large backlog: $10.1B provides multi‑period revenue visibility (46% expected in next 12 months, excluding certain FSA items).
- Other income supports the P&L: interest income and gains helped offset significant interest expense in the quarter (Other income (expense), net: $170,543 in Q3 2025).
- Strategic scale: Ansys adds S&A capability and a diversified product mix, expanding TAM if integration succeeds.

Negative aspects / warning signs (income statement and balance sheet)
- Operating profitability compressed: Operating income fell to $165,269 in Q3 2025 from $360,211 a year earlier - operating expenses surged (R&D, S&M, G&A up materially).
- EPS decline: Diluted EPS fell to $1.50 from $2.61 year‑over‑year in the quarter.
- Massive increase in amortization and non‑cash charges: Amortization of acquired intangibles and acquisition‑related items materially increased cost structure (Amortization of acquired intangible assets in cost of revenue: $46,368 for Q3 2025).
- Heavy new debt / interest burden: interest expense jumped to $(146,502) in Q3 2025 (versus $(11,742) prior year) after Senior Notes and term loan to fund Ansys - raises leverage risk and reduces earnings flexibility.
- Balance sheet risk: goodwill $26.9B and intangibles $13.08B are large and subject to impairment risk if synergies or revenue targets miss.
- Design IP weakness: segment adjusted operating income fell materially (Design IP adjusted operating income Q3 2025: $86,023 vs $169,725 prior year) - revenue pressure from China export controls and a major foundry customer.
- Buyback suspended: $194.3M remains available but the repurchase program is suspended until debt is reduced.

What to watch next / takeaways
- Integration execution and synergies from Ansys will determine whether goodwill and intangible balances are justified; impairment risk exists if realization lags.
- Debt servicing and leverage management: monitor interest costs, covenant compliance and any plans to de‑lever (cash flow vs. required debt service).
- Design IP turnaround: management actions to reallocate resources and sharpen execution will be critical for margin recovery.
- Revenue mix: growth in time‑based vs upfront products and hardware mix will drive quarter‑to‑quarter volatility in revenue and margins.
- Regulatory & geopolitical risks: export control developments (recent Q3 2025 BIS restrictions were rescinded but had impact) continue to affect China business and product flows.

Bottom line: Synopsys grew revenue and strengthened strategic scale with the Ansys acquisition, but profitability and per‑share results are under pressure this quarter due to acquisition‑related costs, higher amortization and sharply higher interest expense. The next 12 months hinge on integration execution, re‑allocation in the IP business, and the company's ability to de‑lever while converting backlog into profitable revenue.